Monday, July 6, 2009

Sonoran Bloom

Every day, we're exposed to toxins in our air, water and food-and even toxins created by our own bodies. TriVita's Sonoran Bloom Nopalea™ harnesses the power of betalains, a rare and potent class of antioxidants that flourish in the Nopal cactus, to rid our bodies of these deadly toxins.

Brazos Minshew, TriVita's Chief Science Officer, he says, "Sometimes our own healthy cells become the focus for disease. This often happens because of toxic exposure. When we eat, drink or breathe a toxin, or if it is absorbed through our skin, our detoxification system works to remove it before the poison can compromise our health."

"Unfortunately, many of today's poisons are simply too strong and they overwhelm our detoxification system and enter healthy cells. These cells now become the target of disease, infection and inflammation."

The causes of inflammation and its effects on the human body is an ongoing process. In a recent newsmax.com article by Dr. Blaylock, he says that "the latest studies show that inflammation is an independent risk factor for heart disease that is much stronger than any measure of cholesterol."

I've included the article written by Dr. Blaylock, in its entirety. Inflammation is a serious problem, but can be defeated with the proper product. I believe that TriVita has that product, Sonoran Bloom Nopalea™. Read the article below and you decide if inflammation is something to take seriously.

Bursting the Bubble of the Statin Myth – It's Inflammation, Not Cholesterol

The dream of all pharmaceutical company CEOs has been to develop a drug that people will need to take for a lifetime to control their ailments. The cholesterol-lowering statin drugs have fulfilled that dream.

Statin drugs have been the biggest moneymaker in history for the pharmaceutical industry, as not only drug companies but also physicians who promote them. But all is not as it appears.

Articles touting the advantages of statin drugs have appeared in the most prestigious medical journals in the world. But scientists working for pharmaceutical companies have written some of them.

Amidst all of the positive article and media hoopla, the public has been denied one essential bit of information: The benefits of statin cholesterol-lowering drugs are no better than taking an aspirin a day. (Dr. Blaylock has also written a special report called, "5 Breakthrough Medical Updates You Need to Know."

In fact, according to the pharmaceutical industry's own studies, the improvements in reducing heart attack and stroke risk are virtually the same as following an aspirin regimen.

We also are not being told that the link between elevated cholesterol levels – even LDL cholesterol – and heart disease is much weaker than measures of inflammation, especially highly sensitive CRP (hsCRP).

The latest studies show that inflammation is an independent risk factor for heart disease that is much stronger than any measure of cholesterol.

A study of two statin drugs, atorvastatin and pravastatin, found that patients with low hsCRP levels had fewer heart attacks no matter their LDL cholesterol level and they had more heart attacks if their hsCRP was elevated, regardless of their LDL cholesterol level.

The same thing has been found for stroke risk. Another recent study examined patients on high and moderate doses of statin drugs. It found that, in both groups, there was no difference in the cholesterol levels of those with cerebrovascular event (stroke) and those without. The only difference was the levels of hsCRP – that is, inflammation.

Few physicians who prescribe statin drugs know that the link between elevated cholesterol levels and strokes has never been established, but the link to inflammation is strong and is supported by many laboratory and clinical studies.

Why won't the drug manufacturers and physicians who promote statin drugs just change their policy and give statin drugs only to people with increased inflammation?

It all comes down to dollars. If I make lowering cholesterol my goal, especially a drastic decrease, I can persuade doctors that everyone, even children, should take them for a lifetime.

Yet, if I use hsCRP or other measures of inflammation as the criteria for prescribing statins, the drugs would not be given to 75 percent to 80 percent of people presently prescribed to use them. That is a massive loss of revenue.

Now that the statin promoters have admitted that inflammation, not elevated cholesterol, is the cause of atherosclerosis, we can examine ways to reduce inflammation in our bodies (and our blood vessels in particular) instead of using statin drugs.

Most chronic diseases and conditions, such as metabolic syndrome and abdominal fat, are associated with chronic inflammation.

- Dr. Blaylock

Wow, did you read that last sentence? "Most chronic diseases and conditions, such as metabolic syndrome and abdominal fat, are associated with chronic inflammation."

I wonder if that's what Hippocrates meant when he said that "all disease is one?" And I wonder if that's why TriVita developed Nopalea™.

TriVita's Nopalea™ (made from the Nopal cactus) specifically targets signs of inflammation in your body and reduces them quickly.[1] Its betalains and other anti-inflammatory ingredients work directly on the fluid surrounding your cells. There, they draw off the toxins and excess water to reduce inflammation and rebalance the cellular environment.

If it's true what Hippocrates says, "all disease is one", and if the majority of diseases are in some way related to inflammation and toxins, doesn't it make sense to try TriVita's Sonoran Bloom Nopalea™, which has the powerful antioxidant betalains.

For information on how you can boost your health and extend your life by reducing chronic inflammation, go to the Sonoran Bloom web site by clicking on the previous link.

Jeffrey Sloe
TriVita Independent Business Affiliate, 12871028
440-725-3729
jeff@internetmarketingadvisors.net

Sources:
[1] Wiese J, McPherson S, Odden MC, Shlipak MG. Arch Intern Med. 2004 Jun 28;164(12):1334-40.

 

No comments: